文献速递重症综合管理与镇静镇痛

重症老年患者在干预性试验中的代表性:一项系统评价

Critically Ill Older Adults' Representation in Intervention Trials: A Systematic Review.
PubMed 文献 · Crit Care Explor · 2024-06-21
一句话结论系统评价253项ICU随机对照试验发现,仅2%报告老年患者比例、5%按年龄分析,7%以高龄为排除标准,老年重症患者的代表性无法确定。

该研究系统检索2009至2022年PubMed、Ovid、CENTRAL和Cochrane中ARDS、脓毒症/休克、营养、镇静、活动五个主题的系统评价,最终纳入216篇系统评价、253项随机对照试验、113090例患者。脓毒症试验最多(78项,31%),其次为营养(62项,25%)、ARDS(39项,15%)、活动(38项,15%)、镇静(36项,14%)。18项试验(7%)以高龄作为排除标准,仅6项试验(2%)报告老年患者比例,10项试验(5%)在分析中考虑年龄。作者认为报告年龄对指导临床个体化治疗很重要,并强调未来试验应纳入老年重症患者以保证结果可推广。

要点

  • 253项ICU随机对照试验中仅6项(2%)报告老年患者比例,老年重症患者在试验中的占比无法确定
  • 18项试验(7%)以高龄作为排除标准,直接限制老年患者进入研究
  • 仅10项试验(5%)在随机分组或结果分析中考虑年龄,年龄是否為效应修饰因素不清楚
  • 脓毒症试验最多(78项,31%),其次营养(62项,25%)、ARDS(39项,15%)、活动(38项,15%)、镇静(36项,14%)
  • 作者认为报告年龄对指导临床个体化治疗很重要,未来试验应纳入老年重症患者以保证结果可推广

适用人群与场景

  • 纳入系统评价覆盖的五类ICU常见主题随机对照试验:急性呼吸窘迫综合征(ARDS)、脓毒症/休克、营养、镇静、活动
  • 研究对象为上述试验中的成年重症患者,共253项随机对照试验、113090例患者

研究设计与关键结果

  • 研究类型:对已发表系统评价的系统评价,检索PubMed、Ovid、CENTRAL和Cochrane 2009年至2022年文献,纳入216篇系统评价、253项随机对照试验、113090例患者
  • 主题分布:脓毒症78项(31%)、营养62项(25%)、ARDS 39项(15%)、活动38项(15%)、镇静36项(14%)
  • 18项试验(7%)设有基于高龄的排除标准
  • 仅6项试验(2%)报告了含老年患者比例信息的年龄分布
  • 10项试验(5%)在分析中考虑年龄,采用按年龄分层评估结局的分析方法

证据类型、等级与局限

  • 证据类型:系统评价(对随机对照试验系统评价的再评价)
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为报告年龄对指导临床个体化治疗很重要
  • 作者认为未来试验应纳入老年重症患者,以确保结果可推广至这一不断增长的人群
  • 原文指出老年重症患者比例无法确定、年龄是否为效应修饰因素不清楚、结果对老年人群的有效程度不明确

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Older adults may be under-represented in critical care research, and results may not apply to this specific population. Our primary objective was to evaluate the prevalence of inclusion of older adults across critical care trials focused on common ICU conditions or interventions. Our secondary objective was to evaluate whether older age was used as a stratification variable for randomization or outcome analysis.

DESIGN SETTING AND SUBJECTS: We performed a systematic review of previously published systematic reviews of randomized controlled trials (RCTs) in critical care. We searched PubMed, Ovid, CENTRAL, and Cochrane from 2009 to 2022. Systematic reviews of any interventions across five topics: acute respiratory distress syndrome (ARDS), sepsis/shock, nutrition, sedation, and mobilization were eligible.

MAIN RESULTS: We identified 216 systematic reviews and included a total of 253 RCTs and 113,090 patients. We extracted baseline characteristics and the reported proportion of older adults. We assessed whether any upper age limit was an exclusion criterion for trials, whether age was used for stratification during randomization or data analysis, and if age-specific subgroup analysis was present. The most prevalent topic was sepsis (78 trials, 31%), followed by nutrition (62 trials, 25%), ARDS (39 trials, 15%), mobilization (38 trials, 15%), and sedation (36 trials, 14%). Eighteen trials (7%) had exclusion criteria based on older age. Age distribution with information on older adults prevalence was given in six trials (2%). Age was considered in the analysis of ten trials (5%) using analytic methods to evaluate the outcome stratified by age.

CONCLUSIONS: In this systematic review, the proportion of older critically ill patients is undetermined, and it is unclear how age is or is not an effect modifier or to what extent the results are valid for older adult groups. Reporting age is important to guide clinicians in personalizing care. These results highlight the importance of incorporating older critically ill patients in future trials to ensure the results are generalizable to this growing population.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Forget MF, Wang HT, Carignan R, et al. Critically Ill Older Adults' Representation in Intervention Trials: A Systematic Review. Crit Care Explor. 2024. PMID: 38919511. doi:10.1097/CCE.0000000000001107

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。